Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michela Villa
Observed names:
M Villa,
M. Villa
Institutions:
University of Milan,
Istituto Nazionale Genetica Molecolare
Observed institutions:
University of Milan,
Azienda Sanitaria Locale di Asti,
A. O. Ordine Mauriziano di Torino,
Istituto Nazionale Genetica Molecolare,
University of Turin
ORCID:
0000-0003-4113-7460
Observed ORCID:
0000-0003-4113-7460
OpenAlex ID:
A5108687485
Current Evidence of the Oncological Benefit-Risk Profile of Hormone Replacement Therapy
2019
·
Marta D’Alonzo
, Valentina Elisabetta Bounous
, et al.
·
Medicina
·
70
PDF
Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy
2014
·
M Adamo
, Daniela Alessi
, et al.
·
Epidemiologia e prevenzione
·
47
Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies?
2018
·
Annamaria Ferrero
, Michela Villa
, et al.
·
Medicine
·
29
Immunonutrition in ovarian cancer: clinical and immunological impact?
2022
·
Annamaria Ferrero
, Daniela Vassallo
, et al.
·
Journal of Gynecologic Oncology
·
21
Development of a preoperative computed tomography score for the management of advanced epithelial ovarian cancer
2019
·
Luca Fuso
, Annamaria Ferrero
, et al.
·
International Journal of Gynecological Cancer
·
9
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature
2021
·
G. Giannone
, G. Scotto
, et al.
·
Gynecologic Oncology
·
6
PDF
Development and clinical application of a tool to identify frailty in elderly patients with gynecological cancers
2023
·
Annamaria Ferrero
, Roberta Massobrio
, et al.
·
International Journal of Gynecological Cancer
·
5
Oral metronomic cyclophosphamide in advanced ovarian cancer: long-lasting clinical response in an elderly frailty patient
2019
·
Michela Villa
, Daniela Attianese
, et al.
·
Anti-Cancer Drugs
·
5
Hormones, Breast Disorders, and Lactation
2020
·
Nicoletta Biglia
, Valentina Elisabetta Bounous
, et al.
·
Endocrinology
·
4
Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients
2024
·
Daniela Attianese
, Roberta Massobrio
, et al.
·
Archives of Gynecology and Obstetrics
·
3
Chemotherapy and uterine sarcomas: a narrative review
2021
·
Annamaria Ferrero
, Daniela Attianese
, et al.
·
Gynecology and Pelvic Medicine
·
2
Cholesterol restores corticostriatal synaptic connectivity in Huntington’s disease through BDNF/TrkB signalling, supporting a role for cholesterol pathways implicated by human genetic modifier studies
2026
·
Allegra Lenci
, Michela Villa
, et al.
·
Pharmacological Research
·
1
143 Development and clinical application of a tool to identify frailty in elderly patients with gynecological cancers
2020
·
A. Ferrero
, M. Villa
, et al.
·
International Journal of Gynecological Cancer
·
1
PDF
Cholesterol nose-to-brain delivery as a possible therapeutic strategy in Huntington’s disease
2026
·
Monica Favagrossa
, Alice Passoni
, et al.
·
Figshare
#645 The impact of advanced chemotherapy lines on survival in recurrent epithelial ovarian cancer: single centre experience
2023
·
Michela Villa
, Enrico Badellino
, et al.
·
International Journal of Gynecological Cancer
PDF
#884 Loco-regional treatment of oligometastatic recurrence in patients with epithelial ovarian cancer: comparison between radiotherapy and surgery
2023
·
Enrico Badellino
, Michela Villa
, et al.
·
International Journal of Gynecological Cancer
PDF
Immunotherapy in Gynaecological Oncology: The Italian Landscape
2023
·
Luca Pace
, Michela Villa
, et al.
·
Clinical and Experimental Obstetrics & Gynecology
PDF
369 Clinical benefit of oral metronomic cyclophosphamide administration in heavily pretreated recurrent epithelial ovarian cancer
2021
·
D Attianese
, E Badellino
, et al.
·
International Journal of Gynecological Cancer
PDF
763P Treatment response to non-platinum therapies in ovarian cancer patients according to BRCA status: A retrospective analysis of a large multicentric cohort
2021
·
G. Giannone
, E. Ghisoni
, et al.
·
Annals of Oncology
599 Real-life tolerability of PARP inhibitors using specific PRO-CTCAE questionnaires: a single centre experience in ovarian cancer
2021
·
R. Massobrio
, M. Villa
, et al.
·
International Journal of Gynecological Cancer
PDF
729 The impact of age and performance status on the management of patients with ovarian cancer: a multicentric study
2021
·
M.E. Laudani
, L. Fuso
, et al.
·
International Journal of Gynecological Cancer
PDF
506 Oral metronomic cyclophosphamide in recurrent ovarian cancer: a single centre experience
2020
·
Daniela Attianese
, Enrico Badellino
, et al.
·
International Journal of Gynecological Cancer
PDF
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: Retrospective analysis of clinical outcomes.
2020
·
Gaia Giannone
, Giulia Scotto
, et al.
·
Journal of Clinical Oncology
Hormones, Breast Disorders, and Lactation
2020
·
Nicoletta Biglia
, Valentina Elisabetta Bounous
, et al.
·
Endocrinology
EP518 ‘Sandwich’ adjuvant chemotherapy and radiotherapy in high risk endometrial cancer: two institution experience
2019
·
A. Ferrero
, R. Danese
, et al.
·
International Journal of Gynecological Cancer
Show more works
View as search
Works count:
28
Citation count:
203
H-index:
6
I10-index:
4
Year
Topic
Type